C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer

被引：0
|
作者：
Tsakonas, G. [1 ]
Hirsch, F. R. [2 ]
Ekman, S. [1 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
c-Met; non-small cell lung cancer; early stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-070
引用
收藏
页码：S2124 / S2125
页数：2
相关论文
共 50 条
  • [1] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [2] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [3] Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
    Fu, Le
    Guo, Wei
    Liu, Bingshan
    Sun, Linlin
    Bi, Zhenghong
    Zhu, Li
    Wang, Xinyan
    Liu, Bin
    Xie, Qian
    Li, Ke
    BIOMARKERS, 2013, 18 (02) : 126 - 135
  • [4] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Satoh, Hiroaki
    Iguchi, Kesato
    Nakamura, Ryota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 314 - 314
  • [5] Adjuvant chemotherapy for surgically resected non-small cell lung cancer
    Heon, Stephanie
    Johnson, Bruce E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03): : S39 - S42
  • [6] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Moskalenko, Yuliia
    Smorodska, Olga
    Deineka, Volodymyr
    Kravets, Oleksandr
    Moskalenko, Roman
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (03): : 239 - 246
  • [7] Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
    Duan, Jianchun
    Yang, Xiaodan
    Zhao, Jun
    Zhuo, Minglei
    Wang, Zhijie
    An, Tongtong
    Bai, Hua
    Wang, Jie
    ONCOTARGET, 2018, 9 (02) : 2660 - 2667
  • [8] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [9] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
  • [10] Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients
    Cappuzzo, F.
    Skokan, M.
    Gajapathy, S.
    Giordano, L.
    Incarbone, M.
    Roncalli, M.
    Terracciano, L.
    Alloisio, M.
    Santoro, A.
    Varella-Garcia, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345